Evidence map›Paper›PMID 41625117›Full record

ArticleSurgical neurology international2025

Hepatoblastoma brain metastasis treated with stereotactic radiosurgery: Illustrative case and literature search.

Muhammad Izhar, Ahed H Kattaa, Yusuke S Hori, Fred C Lam, Armine Tayag, Louisa Ustrzynski, Sara C Emrich, Iris C Gibbs, David J Park, Steven D Chang

Abstract readCase Reports
In one paragraph

Article in Surgical neurology international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Muhammad IzharDepartment of Neurosurgery, Stanford University School of Medicine, Stanford, California, United States.
Ahed H KattaaDepartment of Neurosurgery, Stanford University School of Medicine, Stanford, California, United States.
Yusuke S HoriDepartment of Neurosurgery, Stanford University School of Medicine, Stanford, California, United States.
Fred C LamDepartment of Neurosurgery, Stanford University School of Medicine, Stanford, California, United States.
Armine TayagDepartment of Neurosurgery, Stanford University School of Medicine, Stanford, California, United States.
Louisa UstrzynskiDepartment of Neurosurgery, Stanford University School of Medicine, Stanford, California, United States.
Sara C EmrichDepartment of Neurosurgery, Stanford University School of Medicine, Stanford, California, United States.
Iris C GibbsDepartment of Radiation Oncology, Stanford University School of Medicine, Stanford, California, United States.
David J ParkDepartment of Neurosurgery, Stanford University School of Medicine, Stanford, California, United States.
Steven D ChangDepartment of Neurosurgery, Stanford University School of Medicine, Stanford, California, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Hepatoblastoma (HB) is the most prevalent pediatric liver malignancy, typically affecting children under 5 years of age. Although advances in multimodal therapy, including surgical resection and chemotherapy, have significantly improved survival rates, distant metastases, particularly to the lungs and the brain, remain a critical prognostic challenge. Brain metastases (BMs) from HB are exceedingly rare, with only a limited number of cases reported in the literature, and the management of these lesions is challenging. Stereotactic radiosurgery (SRS) is an increasingly popular treatment option for BM due to its ability to deliver high doses of radiation to the target volume with minimal exposure to surrounding normal tissues. In this paper, we present a rare case of HB with brain metastasis that was treated with SRS for the 1 Case Description: The case was a 4-year-old male with a history of stage IV HB who was diagnosed with a single BM. Post-treatment magnetic resonance images following SRS revealed a reduction in lesion size on 6 Conclusion: SRS may represent a safe and effective treatment modality for HB BM, particularly in patients who are not suitable candidates for surgical resection or systemic therapy. Larger studies with extended follow-up are necessary to more accurately assess the long-term safety, efficacy, and clinical utility of SRS in the management of HB-related BM.

Identifiers

PMID41625117
PMCPMC12860303

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.